98%
921
2 minutes
20
The scarcity of clinical information surrounding rare chromosome disorders poses challenges for parents and clinicians. To bridge this gap for chromosome 6 disorders, the Chromosome 6 Project collects detailed genotype and phenotype data, aiming to provide aberration-specific phenotype information to parents via an interactive website. With input from 32 parents and 21 professionals, including medical doctors, cytogeneticists, health psychologists, and communication specialists, we used a three-round Delphi method to determine the type and amount of health-related information to be presented on this website. A pre-Delphi questionnaire identified key factors for reporting clinical information online, forming the basis for 13 Delphi statements. Consensus was reached for 12 statements. Participants agreed that clinically relevant features should always be reported given their health impact, while parents also emphasized the importance of issues affecting the child's or family's well-being. Feature prevalence was supported as a guide for the order of reported features. To limit information overload, participants agreed on a reporting threshold for certain features. Finally, parents will be able to tailor the amount and type of information they view, with all details remaining accessible for future reference. While focused on chromosome 6 aberrations, these findings can inform the online information needs of families and professionals dealing with other rare genetic disorders.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/ajmg.a.64038 | DOI Listing |
Pol Merkur Lekarski
September 2025
NEAPOLIS UNIVERSITY, NEAPOLIS, CYPRUS.
Objective: Aim: To provide a comprehensive understanding of the profound developmental and medical challenges associated with this condition..
Patients And Methods: Materials and Methods: Τhis study employed a narrative review methodology, drawing upon a wide range of peer-reviewed scientific literature, clinical guidelines, and case studies.
Braz Oral Res
September 2025
Universidade Federal de Minas Gerais - UFMG, School of Dentistry, Department of Restorative Dentistry, Belo Horizonte, MG, Brazil.
This study aimed to determine the prevalence and provide an overview of Down syndrome and child- and mother-associated factors in Brazil from 2010 to 2020. This was a cross-sectional study including epidemiological characteristics related to live births of individuals with and without Down syndrome using the Brazilian government website. The average prevalence of Down syndrome in Brazil was approximately 30.
View Article and Find Full Text PDFBraz Oral Res
September 2025
Universidade Estadual Paulista - Unesp, Araçatuba School of Dentistry, Department of Basic Science, Araçatuba, SP, Brazil.
The purpose of our review was to group the evidence and attempt to provide a consensus on the behavior of salivary flow rate in patients with Down syndrome. Observational studies evaluating salivary flow rate in children and teenagers with Down syndrome compared with non-syndrome individuals were selected. Ten sources of information were researched.
View Article and Find Full Text PDFElife
September 2025
Department of Psychiatry & Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, United States.
Fragile X syndrome (FXS), a leading inherited cause of intellectual disability and autism, is frequently accompanied by sleep and circadian rhythm disturbances. In this study, we comprehensively characterized these disruptions and evaluated the therapeutic potential of a circadian-based intervention in the fragile X mental retardation 1 () knockout (KO) mouse. The KO mice exhibited fragmented sleep, impaired locomotor rhythmicity, and attenuated behavioral responses to light, linked to an abnormal retinal innervation and reduction of light-evoked neuronal activation in the suprachiasmatic nucleus.
View Article and Find Full Text PDFAlzheimers Dement
September 2025
LuMind IDSC Foundation, Woburn, Massachusetts, USA.
Recent innovations in Alzheimer's disease (AD) treatment highlight critical gaps in knowledge about how to support healthy aging of adults with Down syndrome (DS). RAND researchers updated demographic and epidemiological evidence about the DS population to assess the impact of increased investment in treatment innovations for DS-associated Alzheimer's disease (DS-AD). They estimated life expectancy at birth in 2020 to be 55 years, with ≈ 5 years of DS-AD.
View Article and Find Full Text PDF